Expertise in
7
conditions

Dr. Shana E. Mccormack

Pediatric Endocrinology
Office
3401 Civic Center Blvd, 
Philadelphia, PA 
Accepting New Patients
Referral may be required
Before you request
Expertise in
7
conditions
Office
3401 Civic Center Blvd, 
Philadelphia, PA 

Overview

Shana Mccormack is a Pediatric Endocrinologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Mccormack is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Hereditary Ataxia, Obesity, Neurohypophyseal Diabetes Insipidus, and Kearns-Sayre Syndrome.

She is actively involved in clinical research, co-authoring 113 peer reviewed articles and participating in 9 clinical trials. Dr. Mccormack is currently accepting new patients.

Specialties

Pediatric Endocrinology

Licenses

Pediatrics in MA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Avalon Health Care
  • MEDICARE PDP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
View 13 Less Insurance Carriers -

Locations

Office
3401 Civic Center Blvd, Philadelphia, PA 19104

Additional Areas of Focus

Dr. Mccormack has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A 36-Month, Multicenter, Open Label Phase 4 Study to Evaluate the Immunogenicity of Daily SC Metreleptin Treatment in Patients With Generalized Lipodystrophy
A 36-Month, Multicenter, Open Label Phase 4 Study to Evaluate the Immunogenicity of Daily SC Metreleptin Treatment in Patients With Generalized Lipodystrophy
Enrollment Status: Completed
Publish Date: November 26, 2025
Intervention Type: Drug
Study Drug: Metreleptin
Study Phase: Phase 4
Mechanisms of Increased Cardiovascular Disease Risk in Women With Migraine
Mechanisms of Increased Cardiovascular Disease Risk in Women With Migraine
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other
Study Phase: Not Applicable
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Long Term Extension Trial of Setmelanotide (RM-493) for Patients Who Have Completed a Trial of Setmelanotide for the Treatment of Obesity Associated With Genetic Defects Upstream of the MC4 Receptor in the Leptin-melanocortin Pathway
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2/Phase 3
Neurological Measures of Progression in Children With Friedrich Ataxia
Neurological Measures of Progression in Children With Friedrich Ataxia
Enrollment Status: Completed
Publish Date: January 16, 2025
Skeletal Muscle Oxidative Phosphorylation Capacity and Nutrient Homeostasis in Individuals With Primary (Genetic) and Secondary (Obesity-related) Mitochondrial Impairment as Compared to Healthy, Normal-weight Individuals
Skeletal Muscle Oxidative Phosphorylation Capacity and Nutrient Homeostasis in Individuals With Primary (Genetic) and Secondary (Obesity-related) Mitochondrial Impairment as Compared to Healthy, Normal-weight Individuals
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Other
Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
Magnetic Resonance Imaging (MRI) Muscle Phenotyping in Mitochondrial Disease
Enrollment Status: Completed
Publish Date: August 29, 2024
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
Enrollment Status: Completed
Publish Date: August 18, 2023
Intervention Type: Drug
Study Drug: Setmelanotide
Study Phase: Phase 2
A Phase 2a Study of NAD+ Precursor Supplementation in Friedreich's Ataxia
A Phase 2a Study of NAD+ Precursor Supplementation in Friedreich's Ataxia
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug
Study Drug: MIB-626
Study Phase: Phase 2
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Phase 3, Randomized, Double-Blind, Placebo-Controlled, 8-week Clinical Study to Assess the Efficacy, Safety, and Tolerability, of Intranasal Carbetocin (LV-101) in Prader-Willi Syndrome (PWS) With Long Term Follow-Up (CARE-PWS)
Enrollment Status: Completed
Publish Date: July 26, 2022
Intervention Type: Drug
Study Drug: Intranasal carbetocin
Study Phase: Phase 3
View 8 Less Clinical Trials

113 Total Publications

Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.
Journal: The New England journal of medicine
Published: July 08, 2026
Similar Doctors
Expertise in
15
conditions
Dr. Maria G. Vogiatzi
Pediatric Endocrinology
Expertise in
15
conditions
Dr. Maria G. Vogiatzi
Pediatric Endocrinology
Referral may be required
Before you request

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (0.1 miles away)
215-590-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Maria Vogiatzi is a Pediatric Endocrinologist practicing medicine in Philadelphia, Pennsylvania. Dr. Vogiatzi is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Intersex, Klinefelter Syndrome, and Isolated ACTH Deficiency. Dr. Vogiatzi is currently accepting new patients.

Expertise in
7
conditions
Dr. Katherine E. Lord
Pediatric Endocrinology
Expertise in
7
conditions
Dr. Katherine E. Lord
Pediatric Endocrinology
Referral may be required
Before you request

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (0.1 miles away)
215-590-3174
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Katherine Lord is a Pediatric Endocrinologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lord is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Congenital Hyperinsulinism, Low Blood Sugar, Newborn Low Blood Sugar, Sotos Syndrome, and Pancreatectomy. Dr. Lord is currently accepting new patients.

Expertise in
11
conditions
Dr. Vaneeta Bamba
Pediatric Endocrinology
Expertise in
11
conditions
Dr. Vaneeta Bamba
Pediatric Endocrinology
Referral may be required
Before you request

Office

3401 Civic Center Blvd, 
Philadelphia, PA 
 (0.1 miles away)
215-590-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Vaneeta Bamba is a Pediatric Endocrinologist practicing medicine in Philadelphia, Pennsylvania. Dr. Bamba is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Turner Syndrome, Intersex, Mosaicism, Mixed Gonadal Dysgenesis, and Hormone Replacement Therapy (HRT). Dr. Bamba is currently accepting new patients.

Frequently Asked Questions about Dr. Shana E. Mccormack

How do I make an appointment with Dr. Shana E. Mccormack?

You can book an appointment with Dr. Shana E. Mccormack by calling their office at 215-590-3174. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shana E. Mccormack a top-rated expert for Hereditary Ataxia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shana E. Mccormack is classified as an Distinguished expert for Hereditary Ataxia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shana E. Mccormack specialize in?

While Dr. Shana E. Mccormack is a Pediatric Endocrinology, they have specific expertise in Hereditary Ataxia, Obesity, and Neurohypophyseal Diabetes Insipidus. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Shana E. Mccormack participate in research or clinical trials?

Yes. Dr. Shana E. Mccormack has published 113 articles and abstracts on conditions like Hereditary Ataxia. You can view a list of Dr. Shana E. Mccormack's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Shana E. Mccormack accept my insurance?

Dr. Shana E. Mccormack accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 215-590-3174 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccormack's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile